Targeting Dendritic Cells in vivo for Cancer Therapy

Tekijä Caminschi, Irina, Maraskovsky, Eugene, Heath, William Ross
Julkaistu 2012

Dendritic Cell Development in Culture from Thymic Precursor Cells in the Absence of Granulocyte/Macrophage Colony-stimulating Factor

Tekijä Saunders, Dolores, Lucas, Karen, Ismaili, Jamila, Wu, Li, Maraskovsky, Eugene, Dunn, Ashley, Shortman, Ken
Julkaistu 1996

Therapeutic ISCOMATRIX™ adjuvant vaccine elicits effective anti-tumor immunity in the TRAMP-C1 mouse model of prostate cancer

Tekijä Barr, Adele M., Silva, Anabel, Prato, Sandro, Belz, Gabrielle T., Maraskovsky, Eugene, Baz Morelli, Adriana
Julkaisussa Cancer Immunol Immunother (2020)

Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells

Tekijä Hochrein, Hubertus, O'Keeffe, Meredith, Luft, Thomas, Vandenabeele, Stéphane, Grumont, Raelene J., Maraskovsky, Eugene, Shortman, Ken
Julkaistu 2000

Machine learning applied to whole‐blood RNA‐sequencing data uncovers distinct subsets of patients with systemic lupus erythematosus

Tekijä Figgett, William A, Monaghan, Katherine, Ng, Milica, Alhamdoosh, Monther, Maraskovsky, Eugene, Wilson, Nicholas J, Hoi, Alberta Y, Morand, Eric F, Mackay, Fabienne
Julkaisussa Clin Transl Immunology (2019)

A potential association between IL‐3 and type I and III interferons in systemic lupus erythematosus

Tekijä Oon, Shereen, Monaghan, Katherine, Ng, Milica, Hoi, Alberta, Morand, Eric, Vairo, Gino, Maraskovsky, Eugene, Nash, Andrew D, Wicks, Ian P, Wilson, Nicholas J
Julkaisussa Clin Transl Immunology (2019)

A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus

Tekijä Oon, Shereen, Huynh, Huy, Tai, Tsin Yee, Ng, Milica, Monaghan, Katherine, Biondo, Mark, Vairo, Gino, Maraskovsky, Eugene, Nash, Andrew D., Wicks, Ian P., Wilson, Nicholas J.
Julkaisussa JCI Insight (2016)

Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products

Tekijä Jankowski, Wojciech, Park, Yara, McGill, Joseph, Maraskovsky, Eugene, Hofmann, Marco, Diego, Vincent P., Luu, Bernadette W., Howard, Tom E., Kellerman, Roberta, Key, Nigel S., Sauna, Zuben E.
Julkaisussa Blood Adv (2019)

A Novel Cellular Pathway of Antigen Presentation and CD4 T Cell Activation in vivo

Tekijä Scales, Hannah E., Meehan, Gavin R., Hayes, Alan J., Benson, Robert A., Watson, Emma, Walters, Anne, Tomura, Michio, Maraskovsky, Eugene, Garside, Paul, Baz Morelli, Adriana, Brewer, James M.
Julkaisussa Front Immunol (2018)

Therapeutic Effect of IVIG on Inflammatory Arthritis in Mice Is Dependent on the Fc Portion and Independent of Sialylation or Basophils

Tekijä Campbell, Ian K., Miescher, Sylvia, Branch, Donald R., Mott, Patrick J., Lazarus, Alan H., Han, Dongji, Maraskovsky, Eugene, Zuercher, Adrian W., Neschadim, Anton, Leontyev, Danila, McKenzie, Brent S., Käsermann, Fabian
Julkaistu 2014

ISCOMATRIX Adjuvant Combines Immune Activation with Antigen Delivery to Dendritic Cells In Vivo Leading to Effective Cross-Priming of CD8(+) T Cells

Tekijä Duewell, Peter, Kisser, Ulrich, Heckelsmiller, Klaus, Hoves, Sabine, Stoitzner, Patrizia, Koernig, Sandra, Morelli, Adriana B., Clausen, Björn E., Dauer, Marc, Eigler, Andreas, Anz, David, Bourquin, Carole, Maraskovsky, Eugene, Endres, Stefan, Schnurr, Max
Julkaisussa J Immunol (2011)

Complementary Signaling through flt3 and Interleukin-7 Receptor α Is Indispensable for Fetal and Adult B Cell Genesis

Tekijä Sitnicka, Ewa, Brakebusch, Cord, Martensson, Inga-Lill, Svensson, Marcus, Agace, William W., Sigvardsson, Mikael, Buza-Vidas, Natalija, Bryder, David, M.Cilio, Corrado, Ahlenius, Henrik, Maraskovsky, Eugene, Peschon, Jacques J., Jacobsen, Sten Eirik W.
Julkaistu 2003

ISCOMATRIX vaccines mediate CD8(+) T-cell cross-priming by a MyD88-dependent signaling pathway

Tekijä Wilson, Nicholas S, Yang, Becky, Morelli, Adriana Baz, Koernig, Sandra, Yang, Annie, Loeser, Stefanie, Airey, Denise, Provan, Larissa, Hass, Phil, Braley, Hal, Couto, Suzana, Drane, Debbie, Boyle, Jeff, Belz, Gabrielle T, Ashkenazi, Avi, Maraskovsky, Eugene
Julkaistu 2012

Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling

Tekijä Robson, Neil C., Hidalgo, Laura, Mc Alpine, Tristan, Wei, Heng, Martínez, Víctor G., Entrena, Ana, Melen, Gustavo J, MacDonald, Andrew S., Phythian-Adams, Alexander, Sacedón, Rosa, Maraskovsky, Eugene, Cebon, Jonathan, Ramírez, Manuel, Vicente, Angeles, Varas, Alberto
Julkaistu 2014

The dominant role of CD8(+) dendritic cells in cross-presentation is not dictated by antigen capture

Tekijä Schnorrer, Petra, Behrens, Georg M. N., Wilson, Nicholas S., Pooley, Joanne L., Smith, Christopher M., El-Sukkari, Dima, Davey, Gayle, Kupresanin, Fiona, Li, Ming, Maraskovsky, Eugene, Belz, Gabrielle T., Carbone, Francis R., Shortman, Ken, Heath, William R., Villadangos, Jose A.
Julkaistu 2006

A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen

Tekijä Zhao, Rona Y., Mifsud, Nicole A., Xiao, Kun, Chan, Kok-Fei, Oveissi, Sara, Jackson, Heather M., Dimopoulos, Nektaria, Guillaume, Philippe, Knights, Ashley J., Lowen, Tamara, Robson, Neil C., Russell, Sarah E., Scotet, Emmanuel, Davis, Ian D., Maraskovsky, Eugene, Cebon, Jonathan, Luescher, Immanuel F., Chen, Weisan
Julkaistu 2012

Immunodominant CD4(+) responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant

Tekijä Chen, Qiyuan, Jackson, Heather, Parente, Phillip, Luke, Tina, Rizkalla, Mark, Tai, Tsin Yee, Zhu, He-Cheng, Mifsud, Nicole A., Dimopoulos, Nektaria, Masterman, Kelly-Anne, Hopkins, Wendie, Goldie, Heather, Maraskovsky, Eugene, Green, Simon, Miloradovic, Lena, McCluskey, James, Old, Lloyd J., Davis, Ian D., Cebon, Jonathan, Chen, Weisan
Julkaistu 2004

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

Tekijä Caminschi, Irina, Proietto, Anna I., Ahmet, Fatma, Kitsoulis, Susie, Shin Teh, Joo, Lo, Jennifer C. Y., Rizzitelli, Alexandra, Wu, Li, Vremec, David, van Dommelen, Serani L. H., Campbell, Ian K., Maraskovsky, Eugene, Braley, Hal, Davey, Gayle M., Mottram, Patricia, van de Velde, Nicholas, Jensen, Kent, Lew, Andrew M., Wright, Mark D., Heath, William R., Shortman, Ken, Lahoud, Mireille H.
Julkaistu 2008

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

Tekijä Davis, Ian D., Chen, Weisan, Jackson, Heather, Parente, Phillip, Shackleton, Mark, Hopkins, Wendie, Chen, Qiyuan, Dimopoulos, Nektaria, Luke, Tina, Murphy, Roger, Scott, Andrew M., Maraskovsky, Eugene, McArthur, Grant, MacGregor, Duncan, Sturrock, Sue, Tai, Tsin Yee, Green, Simon, Cuthbertson, Andrew, Maher, Darryl, Miloradovic, Lena, Mitchell, Susan V., Ritter, Gerd, Jungbluth, Achim A., Chen, Yao-Tseng, Gnjatic, Sacha, Hoffman, Eric W., Old, Lloyd J., Cebon, Jonathan S.
Julkaistu 2004

Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma

Tekijä Cebon, Jonathan S, Gore, Martin, Thompson, John F, Davis, Ian D, McArthur, Grant A, Walpole, Euan, Smithers, Mark, Cerundolo, Vincenzo, Dunbar, P Rod, MacGregor, Duncan, Fisher, Cyril, Millward, Michael, Nathan, Paul, Findlay, Michael P N, Hersey, Peter, Evans, T R Jeffry, Ottensmeier, Christian Hermann, Marsden, Jeremy, Dalgleish, Angus G, Corrie, Pippa G, Maria, Marples, Brimble, Margaret, Williams, Geoff, Winkler, Sintia, Jackson, Heather M, Endo-Munoz, Liliana, Tutuka, Candani S A, Venhaus, Ralph, Old, Lloyd J, Haack, Dennis, Maraskovsky, Eugene, Behren, Andreas, Chen, Weisan
Julkaisussa J Immunother Cancer (2020)